Notice2022-21406
Healthcare Infection Control Practices Advisory Committee (HICPAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 3, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This virtual meeting is open to the public, limited only by the number of audio and web conference lines (500 audio and web conference lines are available). Time will be available for public comment. Registration is required.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 190 (Monday, October 3, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Page 59792]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-21406]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This virtual meeting is open to
the public, limited only by the number of audio and web conference
lines (500 audio and web conference lines are available). Time will be
available for public comment. Registration is required.
DATES: The meeting will be held on November 3, 2022, from 12 p.m. to
2:30 p.m., EST.
ADDRESSES: To register for this web conference, please go to:
<a href="http://www.cdc.gov/hicpac">www.cdc.gov/hicpac</a>. All registered participants will receive the
meeting link and instructions shortly before the meeting. Please click
the link below to join the webinar: <a href="https://cdc.zoomgov.com/j/1618328215?pwd=NWx1cGZGS3Y0THdzS1RraHBpZFNZZz09">https://cdc.zoomgov.com/j/1618328215?pwd=NWx1cGZGS3Y0THdzS1RraHBpZFNZZz09</a>.
Meeting ID: 161 832 8215.
Passcode: 76683972.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), CDC,
1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027,
Telephone: (404) 718-8039; Email: <a href="/cdn-cgi/l/email-protection#5a1213190a1b191a393e39743d352c"><span class="__cf_email__" data-cfemail="7931303a29383a391a1d1a571e160f">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, DHQP; the Director, NCEZID; the Director,
CDC; and the Secretary, Department of Health and Human Services,
regarding (1) the practice of healthcare infection prevention and
control; (2) strategies for surveillance, prevention, and control of
infections, antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; Isolation
Precautions Guideline Workgroup; Neonatal Intensive Care Unit Guideline
Workgroup; Neonatal Pediatric Surveillance Workgroup; and Dental Unit
Waterlines Guideline Update. Agenda items are subject to change as
priorities dictate.
Public Participation
Oral Public Comment: Time will be available for public comment.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated,
following the last call for comments.
Written Public Comment: The public may submit written comments in
advance of the meeting. Comments should be submitted in writing by
email to the contact person listed above. The deadline for receipt of
written public comment is October 24, 2022. All requests must contain
the submitter's name, address, and organizational affiliation, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length. Written comments received in
advance of the meeting will be included in the official record of the
meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-21406 Filed 9-30-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 3, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.